## Abstract A new hepatobiliary contrast agent for magnetic resonance (MR) imaging, gadolinium‐ethoxybenzy1 (EOB)‐diethylemetriaminepentaacetic acid (DTPA), was compared with Gd‐DTPA to define the potential for improving tumor‐liver contrast in a rodent liver adenocarcinoma model. With a T1‐weighte
Vascular and hepatic enhancements at MR imaging: comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjects
✍ Scribed by Lin, Yen-Heng; Hwang, Ruey-Ming; Chen, Bang-Bin; Hsu, Chao-Yu; Yu, Chih-Wei; Kao, Jia-Horng; Lee, Hsuan-Shu; Liang, Po-Chin; Wei, Shwu-Yuan; Shih, Tiffany Ting-Fang
- Book ID
- 122299130
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 832 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0899-7071
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Purpose: To determine histological and MR imaging differences between areas with Gd‐EOB‐DTPA (gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid) uptake and without in hepatocellular carcinomas (HCCs) as seen on Gd‐EOB‐DTPA‐enhanced hepatobiliary‐phase MR images. ## Materi
## Purpose: To investigate the characteristics of gd-dtpa-dea as a hepatobiliary contrast agent for mr imaging in comparison with those of gd-eob-dtpa. ## Materials and methods: We undertook phantom experiments to assess t1 relaxivity for gd-dtpa-dea, gd-eob-dtpa, and gd-dtpa in human plasma. for